News for 'AstraZeneca PLC'

AstraZeneca to launch one more medicine this year

AstraZeneca to launch one more medicine this year

Rediff.com3 Jun 2003

Close on the heels of introducing drugs for treatment of cancer and cardiovascular diseases, Anglo-Swedish pharmaceutical major AstraZeneca on Tuesday said it would launch one more medicine this year and two next year in India.

Oxford Covid vaccine under lens after error: Report

Oxford Covid vaccine under lens after error: Report

Rediff.com26 Nov 2020

AstraZeneca Plc and the University of Oxford are facing questions about their Covid-19 vaccine and whether regulators would quickly authorise its emergency use after the pharma company acknowledged an error in the vaccine dosage received by some participants and other irregularities and omissions, according to the New York Times.

US to unveil plans for global distribution of vaccine

US to unveil plans for global distribution of vaccine

Rediff.com2 Jun 2021

In the next two weeks, the United States will detail plans to equitably distribute about 80 million (8 crore) COVID-19 vaccine doses globally without 'political requirements' of those receiving them, Secretary of State Antony Blinken has said.

Oxford jabs effective against severe Covid: US trial

Oxford jabs effective against severe Covid: US trial

Rediff.com22 Mar 2021

The Oxford/AstraZeneca vaccine is also being produced as part of a tie-up by the Serum Institute of India.

Accenture cuts full-year outlook as consulting slows further

Accenture cuts full-year outlook as consulting slows further

Rediff.com28 Jun 2013

Its consulting business clients are pulling back IT spending.

US court rejects Ranbaxy' plea to block launch by rival cos

US court rejects Ranbaxy' plea to block launch by rival cos

Rediff.com20 Nov 2014

US District Judge Beryl Howell in Minneapolis denied Ranbaxy's request, the court filing showed.

HCL Tech Q4 net up 42% at Rs 1,210 cr

HCL Tech Q4 net up 42% at Rs 1,210 cr

Rediff.com31 Jul 2013

HCL Technologies Ltd, India's No. 4 IT services exporter, beat expectations with a 41.6 percent rise in quarterly profit, after order wins boosted earnings.

10 things to know about COVID-19 vaccines

10 things to know about COVID-19 vaccines

Rediff.com16 Jan 2021

As India holds its breath for the Covid vaccination to be begin, Sudhir Bisht provides a quick checklist of what you must know about the vaccines that will be administered to citizens.

Ambani says will provide tech for COVID-19 vaccination drive

Ambani says will provide tech for COVID-19 vaccination drive

Rediff.com15 Dec 2020

As India gets ready to roll out one of the largest vaccine programmes, billionaire Mukesh Ambani on Tuesday said his group is working with authorities to provide technology tools and backbone for mass inoculation against COVID-19. Ambani's telecom venture Jio was rolled out four years back, offering free voice calling and dirt-cheap data. Today, Jio is India's largest telecom operator with over 400 million users, each connected to the internet. At a Facebook event, Ambani said the government's digital push kept the country running even during the pandemic and is now helping in the rollout of one of the largest vaccination programmes.

IOC reassures anxious Japan Olympics will be safe

IOC reassures anxious Japan Olympics will be safe

Rediff.com19 May 2021

IOC chief said he believed more than 80 per cent of residents of the Olympic Village would be vaccinated or booked for vaccination ahead of the Games

US President Biden announces COVID vaccine sharing plan

US President Biden announces COVID vaccine sharing plan

Rediff.com3 Jun 2021

The Biden administration had been under pressure to send the excess COVID-19 vaccines with the US to nations like India, which are facing severe vaccine shortages.

Ranbaxy sues US FDA for revoking drug approvals

Ranbaxy sues US FDA for revoking drug approvals

Rediff.com18 Nov 2014

FDA had cancelled Ranbaxy's approvals to launch generic Nexium, Valcyte

Japan, eyeing Olympics, lines up half-billion doses of COVID-19 vaccine

Japan, eyeing Olympics, lines up half-billion doses of COVID-19 vaccine

Rediff.com28 Aug 2020

Some critics contend that Japan's rush to secure supplies is driven largely by a political desire to show the world it is fully committed to hosting the Games.

Investors concerned about Wockhardt

Investors concerned about Wockhardt

Rediff.com17 Oct 2013

The rap from both the US and UK drug regulators, including the latest one from the latter, has hit the scrip.

Pfizer set to buy Allergan for more than $150 bn

Pfizer set to buy Allergan for more than $150 bn

Rediff.com23 Nov 2015

The deal would involve Pfizer paying with 11.3 of its shares for each Allergan share.

Sensex ends flat after hitting life-time high of 28,283

Sensex ends flat after hitting life-time high of 28,283

Rediff.com18 Nov 2014

Roadshows will be held in Singapore, Hong Kong, London, New York and Boston, NTPC gained close to 1%.